FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
WallachBeth Capital downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Buy to Sell with a price target of $5.50.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum... More
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) resumed trading. Shares are currently down over 35 percent in the after-hours session.... More
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) trading halted for news.... More

